Form 4: Cibus Inc. Director Gerhard Prante Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Director Gerhard Prante sold 1,150 shares of Cibus Inc. stock at $2.42 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Gerhard Prante, a director at Cibus Inc., sold 1,150 shares of Class A Common Stock.
- The sale occurred on January 29, 2025, at a price of $2.42 per share.
- The transaction was executed automatically under a Rule 10b5-1 trading plan adopted on August 16, 2024.
- Following the transaction, Prante directly owns 29,557 shares of Cibus Inc. stock.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of an insider sale under a pre-arranged plan, which is neither positive nor negative in itself. It is a neutral event.
Risks
- Sales by insiders, even under pre-arranged plans, can sometimes be perceived negatively by the market.
Industry Context
This is a routine disclosure of an insider transaction. Such filings are common and expected in the normal course of business for publicly traded companies.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with regulatory requirements.
- The use of a 10b5-1 trading plan is a common method for insiders to sell shares while avoiding accusations of trading on non-public information. Many companies and their directors use these plans.
Stakeholder Impact
- The sale may have a minor impact on shareholder sentiment, but it is unlikely to be significant given the pre-planned nature of the transaction.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Date the 10b5-1 trading plan was adopted by Gerhard Prante. |
| 01/29/2025 | Date of the stock sale transaction. |
| 01/30/2025 | Date of the Form 4 filing. |
Keywords
insider trading, Form 4, 10b5-1 trading plan, stock sale, Cibus Inc., Gerhard Prante, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.